Nathanael R. Fillmore
Topics / Hematologic Malignancies
Topic

Hematologic Malignancies

Fillmore has investigated the prognostic determinants and comorbidities associated with hematologic malignancies, with a particular focus on multiple myeloma and acute myeloid leukemia. His research identifies peripheral blood counts, including lymphocyte, monocyte, and platelet levels, as accessible biomarkers for predicting survival in myeloma patients. Additionally, he has examined the impact of mental health comorbidities, socioeconomic disparities, and the increased risk of thromboembolic events and severe COVID-19 within these patient populations.

U.S. Veterans and VA Data 11 Retrospective Cohort Study 8 Patient Outcomes 7 Risk Factors 7 Multiple Myeloma 6 Electronic Health Records 5 Overall Survival 4 Real World Evidence 4 COVID-19 4 Health Disparities 3 Biomarkers 3 Survival Analysis 3

Publications (12)

2023

Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System.

Kylee L. Martens†, Ang Li†, Jennifer La, Sarah B. May, Kaitlin N. Swinnerton, Hannah Tosi, Danne C. Elbers, Nhan V. Do, Mary T. Brophy, J. Michael Gaziano, Saran Lotfollahzadeh, Vipul Chitalia, Katya Ravid, Nathanael R. Fillmore† Equal first authorship

JAMA Network Open6(6), e2317945
U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Cancer-Associated Thrombosis Health Disparities
2023

Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.

Jennifer La†, Clark DuMontier†, Hamza Hassan, Maya Abdallah, Camille Edwards, Karina Verma, Grace Ferri, Mayuri Dharne, Cenk Yildirim, June Corrigan, J. Michael Gaziano, Nhan V. Do, Mary T. Brophy, Jane A. Driver, Nikhil C. Munshi, Nathanael R. Fillmore† Equal first authorship

Pharmacoepidemiology and Drug Safety32(5), 558-566
U.S. Veterans and VA Data Electronic Health Records Multiple Myeloma VA Cancer Registry Algorithm Validation